Business Standard

Monday, December 23, 2024 | 01:06 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Biocon's Insulin Glargine launched in Japan

Image

Capital Market

Following approval of Japanese Regulator last quarter

Biocon announced that following the receipt of approval for its Insulin Glargine from the Japanese Regulator last quarter, its partner FUJIFILM Pharma Co. (FFP) has launched the product in Japan.

Insulin Glargine BS Injection Kit has been developed and manufactured by Biocon, and is being commercialised by FFP in Japan.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 15 2016 | 9:21 AM IST

Explore News